Merck & Co Inc
NYSE: MRK
$99.65
-$1.33 (-1.3%)
Closing Price on January 14, 2025
MRK Articles
Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan Consumer Sentiment Index rose more than expected, but even that...
Published:
Last Updated:
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring charge of $300 million....
Published:
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is the conclusion of a new study by Booz & Co., the conclusion is misleading. Booz...
Published:
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
Published:
Last Updated:
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and more...
Published:
Last Updated:
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke says the Fed may have to act if inflation falls below targets. (Reuters)...
Published:
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month bond. The participation rate was strong enough that this still shows...
Published:
Last Updated:
Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith and credit of the United States, dismal GDP data, and ongoing weak...
Published:
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US Food & Drug...
Published:
Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The results of both drug behemoths are largely in line with analysts...
Published:
Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000 people. These employees can leave with the knowledge that they have...
Published:
Earnings season is in full throttle and many major companies are due to report in the week ahead. Some of the key reports we are featuring for detailed earnings previews are the following: Baidu,...
Published:
Last Updated:
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition. While this is a challenge...
Published:
No industry was able to avoid short selling activity, particularly among its largest companies. Tech, automotive, conglomerates, consumer goods, and financial shares were all under pressure, and big...
Published:
Now that the 10-Year Treasury Note has been back to close to the 3.00% yields again, we wanted to see which Dow Jones Industrial Average components had a higher dividend yield than the 10-Year...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.